It typically affects older individuals, with a higher prevalence in women, and is frequently associated with Janus kinase 2 (JAK2) mutations. While many cases follow an indolent course, major thrombotic events such as pulmonary embolism may occur. Here, JAK2 is linked to pulmonary embolism.